BPG is committed to discovery and dissemination of knowledge
Articles Published Processes Featured Articles Journals Submit a Manuscript
Cited by in CrossRef
For: Tarantino G, Savastano S, Colao A. Hepatic steatosis, low-grade chronic inflammation and hormone/growth factor/adipokine imbalance. World J Gastroenterol 2010; 16(38): 4773-4783 [PMID: 20939105 DOI: 10.3748/wjg.v16.i38.4773]
URL: https://www.wjgnet.com/1007-9327/full/v16/i38/4773.htm
(0) (0) (21826) (184)
Number Citing Articles
1
Parveen Bazard, Jennifer Pineros, Robert D. Frisina, Mark A. Bauer, Alejandro A. Acosta, Lauren R. Paganella, Dominika Borakiewicz, Mark Thivierge, Freyda L. Mannering, Xiaoxia Zhu, Bo Ding. Cochlear Inflammaging in Relation to Ion Channels and Mitochondrial Functions. Cells 2021; 10(10) doi: 10.3390/cells10102761
2
Yaxi Chen, Zac Varghese, Xiong Z. Ruan. The molecular pathogenic role of inflammatory stress in dysregulation of lipid homeostasis and hepatic steatosis. Genes & Diseases 2014; 1(1) doi: 10.1016/j.gendis.2014.07.007
3
Chang‐Jiang Yu, Qiu‐Shi Wang, Ming‐Ming Wu, Bin‐Lin Song, Chen Liang, Jie Lou, Liang‐Liang Tang, Xiao‐Di Yu, Na Niu, Xu Yang, Bao‐Long Zhang, Yao Qu, Yang Liu, Zhi‐Chao Dong, Zhi‐Ren Zhang. TRUSS Exacerbates NAFLD Development by Promoting IκBα Degradation in Mice. Hepatology 2018; 68(5) doi: 10.1002/hep.30066
4
Midori Honma, Shojiro Sawada, Yoshiyuki Ueno, Keigo Murakami, Tetsuya Yamada, Junhong Gao, Shinjiro Kodama, Tomohito Izumi, Kei Takahashi, Sohei Tsukita, Kenji Uno, Junta Imai, Eiji Kakazu, Yasuteru Kondo, Kei Mizuno, Naoki Kawagishi, Tooru Shimosegawa, Hideki Katagiri. Selective insulin resistance with differential expressions of IRS-1 and IRS-2 in human NAFLD livers. International Journal of Obesity 2018; 42(9) doi: 10.1038/s41366-018-0062-9
5
Lizhi Liu, Danjing Chen, Shiyuan Wang, Wen Si, He Zhang, Yijun Jiang, Yongfeng Cai, Shanghua Xu, Xian-e Peng. Nonlinear associations of remnant cholesterol/high-density lipoprotein cholesterol ratio with the risk of metabolic-associated fatty liver disease: a cross-sectional study. BMC Gastroenterology 2026; 26(1) doi: 10.1186/s12876-026-04739-z
6
Shozo Miyauchi, Teruki Miyake, Masumi Miyazaki, Toru Eguchi, Tetsuji Niiya, Shin Yamamoto, Hidenori Senba, Shinya Furukawa, Bunzo Matsuura, Yoichi Hiasa. Free testosterone concentration is inversely associated with markers of liver fibrosis in men with type 2 diabetes mellitus. Endocrine Journal 2017; 64(12) doi: 10.1507/endocrj.EJ17-0225
7
Maria Arconzo, Elena Piccinin, Antonio Moschetta. Increased risk of acute liver failure by pain killer drugs in NAFLD: Focus on nuclear receptors and their coactivators. Digestive and Liver Disease 2021; 53(1) doi: 10.1016/j.dld.2020.05.034
8
Baran Ghezelbash, Nader Shahrokhi, Mohammad Khaksari, Gholamreza Asadikaram, Maryam Shahrokhi, Sara Shirazpour. Protective Roles of Shilajit in Modulating Resistin, Adiponectin, and Cytokines in Rats with Non-alcoholic Fatty Liver Disease. Chinese Journal of Integrative Medicine 2022; 28(6) doi: 10.1007/s11655-022-3307-3
9
Mohamed El‐Kassas, Hala Mostafa, Wessam Abdellatif, Sohier Shoman, Gamal Esmat, Mayur Brahmania, Hongqun Liu, Samuel S. Lee. Lubiprostone Reduces Fat Content on MRI‐PDFF in Patients With MASLD: A 48‐Week Randomised Controlled Trial. Alimentary Pharmacology & Therapeutics 2025; 61(4) doi: 10.1111/apt.18478
10
Sharmin Akter. Non-alcoholic Fatty Liver Disease and Steatohepatitis: Risk Factors and Pathophysiology. Middle East Journal of Digestive Diseases 2022; 14(2) doi: 10.34172/mejdd.2022.270
11
Tianran Shen, Xu Chen, Yanping Li, Xilan Tang, Xinwei Jiang, Chao Yu, Yuanzhu Zheng, Honghui Guo, Wenhua Ling. Interleukin-17A exacerbates high-fat diet-induced hepatic steatosis by inhibiting fatty acid β-oxidation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2017; 1863(6) doi: 10.1016/j.bbadis.2017.01.027
12
Preena John, Nirav Bhatia, Pravin Kale, Gaurav Doshi. Benefit of Betaine in Isoniazid-Rifampicin-Induced Hepatotoxicity in Rats. Iranian Journal of Toxicology 2023; 17(4) doi: 10.61186/IJT.17.4.61
13
Otto Kučera, Halka Lotková, Pavla Staňková, Miroslav Podhola, Tomáš Roušar, Vojtěch Mezera, Zuzana Červinková. Is rat liver affected by non-alcoholic steatosis more susceptible to the acute toxic effect of thioacetamide?. International Journal of Experimental Pathology 2011; 92(4) doi: 10.1111/j.1365-2613.2011.00765.x
14
Farah Gulzar, Shadab Ahmad, Sushmita Singh, Pawan Kumar, Aditya Sharma, Akhilesh K. Tamrakar. NOD1 activation in 3T3-L1 adipocytes confers lipid accumulation in HepG2 cells. Life Sciences 2023; 316 doi: 10.1016/j.lfs.2023.121400
15
Jihye Hong, Sera Kim, Hyun-Sook Kim. Hepatoprotective Effects of Soybean Embryo by Enhancing Adiponectin-Mediated AMP-Activated Protein KinaseαPathway in High-Fat and High-Cholesterol Diet-Induced Nonalcoholic Fatty Liver Disease. Journal of Medicinal Food 2016; 19(6) doi: 10.1089/jmf.2015.3604
16
Ayman M. Mahmoud. Hesperidin protects against cyclophosphamide-induced hepatotoxicity by upregulation of PPARγ and abrogation of oxidative stress and inflammation. Canadian Journal of Physiology and Pharmacology 2014; 92(9) doi: 10.1139/cjpp-2014-0204
17
Erli Pei, Yang Liu, Weiqing Jiang, Songruo Lin, Lei Huang, Moubin Lin, Li Cai. Sleeve gastrectomy attenuates high fat diet-induced non-alcoholic fatty liver disease. Lipids in Health and Disease 2018; 17(1) doi: 10.1186/s12944-018-0875-5
18
Yuting Sun, Xinlei Miao, Manling Hu, Xiaoling Xie, Shuang Liu, Ziping Song, Jiayi Deng, Fei Xu, Meng Li, Yangxuan He, Song Leng. Remnant cholesterol and its variability independent of low density lipoprotein cholesterol predict metabolic dysfunction associated steatotic liver disease. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-88000-9
19
Yan-Fei He, Ning Bian, Huan-Zhi Wang, Xiao-Dong Hu, Jun-Qiang Liu, Shuang-Feng Lu, Ni Wu, Qin-Tong He, Hu-Ming Li. Correlation between non-alcoholic fatty liver disease and erectile dysfunction: A systematic narrative review. World Journal of Hepatology 2026; 18(4): 115456 doi: 10.4254/wjh.v18.i4.115456
20
Longyi Liu, Youya Niu, Zhaolai Guo, Chengchen Wang, Hai Liu, Ji Yang, Peng Gao, Ping Xiang. Environmental manganese exposure accelerates metabolic dysfunction-associated steatotic liver disease by lipotoxic endoplasmic reticulum stress. Environmental Chemistry and Ecotoxicology 2025; 7 doi: 10.1016/j.enceco.2025.10.014
21
Xi‐Mei Zhang, Lin Guo, Xiang Huang, Qiu‐Ming Li, Mei‐Hua Chi. 4‐Hydroxynonenal Regulates TNF‐α Gene Transcription Indirectly via ETS1 and microRNA‐29b in Human Adipocytes Induced From Adipose Tissue‐Derived Stromal Cells. The Anatomical Record 2016; 299(8) doi: 10.1002/ar.23371
22
Luigi Barrea, Paolo Emidio Macchia, Giovanni Tarantino, Carolina Di Somma, Elena Pane, Nicola Balato, Maddalena Napolitano, Annamaria Colao, Silvia Savastano. Nutrition: a key environmental dietary factor in clinical severity and cardio-metabolic risk in psoriatic male patients evaluated by 7-day food-frequency questionnaire. Journal of Translational Medicine 2015; 13(1) doi: 10.1186/s12967-015-0658-y
23
Farouk K. El-Baz, Dalia O. Saleh, Gehad A. Abdel Jaleel, Rehab A. Hussein. Attenuation of Age-Related Hepatic Steatosis by Dunaliella salina Microalgae in Senescence Rats through the Regulation of Redox Status, Inflammatory Indices, and Apoptotic Biomarkers. Advances in Pharmacological and Pharmaceutical Sciences 2020; 2020 doi: 10.1155/2020/3797218
24
Laís Rossi Perazza, Noëmie Daniel, Marie-Julie Dubois, Geneviève Pilon, Thibault Vincent Varin, Mylène Blais, José Luis Martinez Gonzales, Michaël Bouchard, Claude Asselin, Martin Lessard, Yves Pouliot, Denis Roy, André Marette. Distinct Effects of Milk-Derived and Fermented Dairy Protein on Gut Microbiota and Cardiometabolic Markers in Diet-Induced Obese Mice. The Journal of Nutrition 2020; 150(10) doi: 10.1093/jn/nxaa217
25
Xia Liu, Runzhou Sun, Zhaozhen Li, Ruixin Xiao, Pengfei Lv, Xiangrong Sun, Mark A. Olson, Yanling Gong. Luteolin alleviates non-alcoholic fatty liver disease in rats via restoration of intestinal mucosal barrier damage and microbiota imbalance involving in gut-liver axis. Archives of Biochemistry and Biophysics 2021; 711 doi: 10.1016/j.abb.2021.109019
26
Giovanni Tarantino, Vincenzo Citro, Mauro Cataldi. Findings from Studies Are Congruent with Obesity Having a Viral Origin, but What about Obesity-Related NAFLD?. Viruses 2021; 13(7) doi: 10.3390/v13071285
27
Luigi Barrea, Ludovica Verde, Martina Galasso, Silvia Savastano, Annamaria Colao, Giovanna Muscogiuri. Very low energy ketogenic therapy: an anti-inflammatory medical nutritional approach for MASLD in obesity. Journal of Translational Medicine 2025; 23(1) doi: 10.1186/s12967-025-07295-4
28
Julie Lasselin, Eric Magne, Cédric Beau, Patrick Ledaguenel, Sandra Dexpert, Agnès Aubert, Sophie Layé, Lucile Capuron. Adipose Inflammation in Obesity: Relationship With Circulating Levels of Inflammatory Markers and Association With Surgery-Induced Weight Loss. The Journal of Clinical Endocrinology & Metabolism 2014; 99(1) doi: 10.1210/jc.2013-2673
29
Gabsik Yang, Hye Eun Lee, Joo Young Lee. A pharmacological inhibitor of NLRP3 inflammasome prevents non-alcoholic fatty liver disease in a mouse model induced by high fat diet. Scientific Reports 2016; 6(1) doi: 10.1038/srep24399
30
Xing-Yu Chen, Cong Wang, Yi-Zhou Huang, Li-Li Zhang. Nonalcoholic fatty liver disease shows significant sex dimorphism. World Journal of Clinical Cases 2022; 10(5): 1457-1472 doi: 10.12998/wjcc.v10.i5.1457
31
Heekyung Choi, Juhyeong Hong, Yuha Seo, Seung‐Hwan Joo, Hanseok Lim, Shayan Fakhraei Lahiji, Yong‐Hee Kim. Self‐Assembled Oligopeptoplex‐Loaded Dissolving Microneedles for Adipocyte‐Targeted Anti‐Obesity Gene Therapy. Advanced Materials 2024; 36(16) doi: 10.1002/adma.202309920
32
Allison J. Wu, Sheryl L. Rifas‐Shiman, Elsie M. Taveras, Emily Oken, Marie‐France Hivert. Associations of DXA‐measured abdominal adiposity with cardio‐metabolic risk and related markers in early adolescence in Project Viva. Pediatric Obesity 2021; 16(2) doi: 10.1111/ijpo.12704
33
Angela Di Porzio, Valentina Barrella, Cristina Gatto, Luisa Cigliano, Maria Stefania Spagnuolo, Raffaella Crescenzo, Ida Romano, Gianluigi Mauriello, Susanna Iossa, Arianna Mazzoli. Protective effect of probiotic Limosilactobacillus reuteri DSM17938 against western diet-induced obesity and associated metabolic alterations. Journal of Functional Foods 2023; 109 doi: 10.1016/j.jff.2023.105805
34
Beata Kasztelan-Szczerbinska, Agata Surdacka, Maria Slomka, Jacek Rolinski, Krzysztof Celinski, Agata Smolen, Mariusz Szczerbinski. Association of Serum Adiponectin, Leptin, and Resistin Concentrations with the Severity of Liver Dysfunction and the Disease Complications in Alcoholic Liver Disease. Mediators of Inflammation 2013; 2013 doi: 10.1155/2013/148526
35
Hiroki Yoshioka, Shiori Fukaya, Sarah Tominaga, Akito Nagatsu, Nobuhiko Miura, Tohru Maeda. Protective effect of the Kampo formula “Juzen-taiho-to” on isoniazid- and rifampicin-induced hepatotoxicity in mice. Fundamental Toxicological Sciences 2019; 6(1) doi: 10.2131/fts.6.25
36
Taghi Badali, Sara Arefhosseini, Farnaz Rooholahzadegan, Helda Tutunchi, Mehrangiz Ebrahimi-Mameghani. The effect of DASH diet on atherogenic indices, pro-oxidant-antioxidant balance, and liver steatosis in obese adults with non-alcoholic fatty liver disease: A double-blind controlled randomized clinical trial. Health Promotion Perspectives 2023; 13(1) doi: 10.34172/hpp.2023.10
37
D. Gyamfi, H.E. Everitt, V.B. Patel. Bioactive Food as Dietary Interventions for Liver and Gastrointestinal Disease. 2013;  doi: 10.1016/B978-0-12-397154-8.00013-0
38
Irina V. Kurbatova, Lyudmila V. Topchieva, Olga P. Dudanova, Anastasia A. Shipovskaya. Role of MMP-2 and MMP-9 in the Relationship between Inflammation, Fibrosis, and Apoptosis during Progression of Non-Alcoholic Fatty Liver Disease and Diagnostic Significance of Plasma Levels of Their Active Forms. Biochemistry (Moscow) 2024; 89(11) doi: 10.1134/S0006297924110130
39
Sacha Robert, Thomas Gicquel, Aude Bodin, Vincent Lagente, Elisabeth Boichot, Matias A Avila. Characterization of the MMP/TIMP Imbalance and Collagen Production Induced by IL-1β or TNF-α Release from Human Hepatic Stellate Cells. PLOS ONE 2016; 11(4) doi: 10.1371/journal.pone.0153118
40
Christoph Grander, Felix Grabherr, Herbert Tilg. Non-alcoholic fatty liver disease: pathophysiological concepts and treatment options. Cardiovascular Research 2023; 119(9) doi: 10.1093/cvr/cvad095
41
Jae-Yeo Park, Younghwa Kim, Jee Ae Im, Hyangkyu Lee. Oligonol suppresses lipid accumulation and improves insulin resistance in a palmitate-induced in HepG2 hepatocytes as a cellular steatosis model. BMC Complementary and Alternative Medicine 2015; 15(1) doi: 10.1186/s12906-015-0709-1
42
Luciana L.A. Ventura, Nathália C.L. Fortes, Helton C. Santiago, Marcelo V. Caliari, Maria A. Gomes, Dirce R. Oliveira. Obesity-induced diet leads to weight gain, systemic metabolic alterations, adipose tissue inflammation, hepatic steatosis, and oxidative stress in gerbils (Meriones unguiculatus). PeerJ 2017; 5 doi: 10.7717/peerj.2967
43
Natália Perin Schmidt, Milena Henrique Ferri, Patrícia Molz, Brenda Santos Fraga, Priscila Dutra Silveira, Daiana Rodrigues dos Santos, Juan Andres Cuadro Montanez, Gabriela Merker Breyer, Amanda de Souza da Motta, Marilene Porawski, Alethea Gatto Barschak, Renata Padilha Guedes, Márcia Giovenardi. Effects of Lacticaseibacillus rhamnosus LB1.5 as potential probiotic supplement on the liver and adipose tissue of adult male mice to a high-fat diet. Molecular and Cellular Biochemistry 2025; 480(10) doi: 10.1007/s11010-025-05344-6
44
Otto Kučera, Tomáš Roušar, Pavla Staňková, Lenka Haňáčková, Halka Lotková, Miroslav Podhola, Zuzana Červinková. Susceptibility of rat non‐alcoholic fatty liver to the acute toxic effect of acetaminophen. Journal of Gastroenterology and Hepatology 2012; 27(2) doi: 10.1111/j.1440-1746.2011.06807.x
45
Anna Alisi, Anna Pastore, Sara Ceccarelli, Nadia Panera, Daniela Gnani, Giovannella Bruscalupi, Mara Massimi, Giulia Tozzi, Fiorella Piemonte, Valerio Nobili. Emodin Prevents Intrahepatic Fat Accumulation, Inflammation and Redox Status Imbalance During Diet-Induced Hepatosteatosis in Rats. International Journal of Molecular Sciences 2012; 13(2) doi: 10.3390/ijms13022276
46
Ruanchang Chen, Fangzheng Zhou, Jiayao Zhang, Huanjun Tong, Baochun Lu. Nine anthropometric indices predict hepatic steatosis and assess liver health in adolescents: a population-based study. Frontiers in Pediatrics 2025; 13 doi: 10.3389/fped.2025.1558023
47
N. Frank, E. M. Tadros. Insulin dysregulation. Equine Veterinary Journal 2014; 46(1) doi: 10.1111/evj.12169
48
Raika Jamali, Mohsen Razavizade, Abbas Arj, Mohammad Hossein Aarabi. Serum adipokines might predict liver histology findings in non-alcoholic fatty liver disease. World Journal of Gastroenterology 2016; 22(21): 5096-5103 doi: 10.3748/wjg.v22.i21.5096
49
Jia Liu, Yuan Xu, Yanjin Hu, Guang Wang. The role of fibroblast growth factor 21 in the pathogenesis of non-alcoholic fatty liver disease and implications for therapy. Metabolism 2015; 64(3) doi: 10.1016/j.metabol.2014.11.009
50
Ayman M. Mahmoud, Mousa O. Germoush, Ayman S. Soliman. Berberine Attenuates Isoniazid-Induced Hepatotoxicity by Modulating Peroxisome Proliferator-Activated Receptor γ, Oxidative Stress and Inflammation. International Journal of Pharmacology 2014; 10(8) doi: 10.3923/ijp.2014.451.460
51
Linlin Shi, Jie Wang, Yuan Wang, Yi Feng. MDG-1, an Ophiopogon polysaccharide, alleviates hyperlipidemia in mice based on metabolic profile of bile acids. Carbohydrate Polymers 2016; 150 doi: 10.1016/j.carbpol.2016.05.008
52
Han Zhou, Lei Tian, Yiting Wu, Sibin Liu. Computed tomography-measured body composition can predict long-term outcomes for stage I-III colorectal cancer patients. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1420917
53
Mikiko Watanabe, Renata Risi, Elisabetta Camajani, Savina Contini, Agnese Persichetti, Dario Tuccinardi, Ilaria Ernesti, Stefania Mariani, Carla Lubrano, Alfredo Genco, Giovanni Spera, Lucio Gnessi, Sabrina Basciani. Baseline HOMA IR and Circulating FGF21 Levels Predict NAFLD Improvement in Patients Undergoing a Low Carbohydrate Dietary Intervention for Weight Loss: A Prospective Observational Pilot Study. Nutrients 2020; 12(7) doi: 10.3390/nu12072141
54
Asier Benito-Vicente, Kepa B. Uribe, Noemi Rotllan, Cristina M. Ramírez, Shifa Jebari-Benslaiman, Leigh Goedeke, Alberto Canfrán-Duque, Unai Galicia-García, Diego Saenz De Urturi, Patricia Aspichueta, Yajaira Suárez, Carlos Fernández-Hernando, Cesar Martín. miR-27b Modulates Insulin Signaling in Hepatocytes by Regulating Insulin Receptor Expression. International Journal of Molecular Sciences 2020; 21(22) doi: 10.3390/ijms21228675
55
Simona Marchisello, Antonino Di Pino, Roberto Scicali, Francesca Urbano, Salvatore Piro, Francesco Purrello, Agata Rabuazzo. Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview. International Journal of Molecular Sciences 2019; 20(8) doi: 10.3390/ijms20081948
56
Yan Zhang, Caixia Wang, Ruiqi Jia, Jianfeng Zhou, Longfei Chen, Zhaoji Zhang, Zhiyang Jiang, Yameng Wang, Xiaozhi Rong, Yong Jiang. Protozoan-mediated long-term trophic transfer of combined pollutants: Implications for organ development in higher-trophic-level predator. Environmental Chemistry and Ecotoxicology 2025; 7 doi: 10.1016/j.enceco.2025.09.004
57
Mitchell Bijnen, Marleen M. J. van Greevenbroek, Carla J. H. van der Kallen, Jean L. Scheijen, Marjo P. H. van de Waarenburg, Coen D. A. Stehouwer, Kristiaan Wouters, Casper G. Schalkwijk. Hepatic Fat Content and Liver Enzymes Are Associated with Circulating Free and Protein-Bound Advanced Glycation End Products, Which Are Associated with Low-Grade Inflammation: The CODAM Study. Journal of Diabetes Research 2019; 2019 doi: 10.1155/2019/6289831
58
Patricia S. Castillo-Flores, Itzayana Rodríguez-Antonio, Misael Uribe, Norberto C. Chávez-Tapia, Eduardo E. Montalvo-Javé, Natalia Nuño-Lámbarri. Reframing MASLD: A Hepatic Condition With Systemic Clinical Impact. Journal of Clinical and Experimental Hepatology 2026; 16(6) doi: 10.1016/j.jceh.2026.103631
59
Farnaz Rooholahzadegan, Sara Arefhosseini, Helda Tutunchi, Taghi Badali, Manuchehr Khoshbaten, Mehrangiz Ebrahimi-Mameghani. The effect of DASH diet on glycemic response, meta-inflammation and serum LPS in obese patients with NAFLD: a double-blind controlled randomized clinical trial. Nutrition & Metabolism 2023; 20(1) doi: 10.1186/s12986-023-00733-4
60
Giovanni Tarantino, Rossella Valentino, Carolina Di Somma, Vittoria D'Esposito, Federica Passaretti, Genoveffa Pizza, Valentina Brancato, Francesco Orio, Pietro Formisano, Annamaria Colao, Silvia Savastano. Bisphenol A in polycystic ovary syndrome and its association with liver–spleen axis. Clinical Endocrinology 2013; 78(3) doi: 10.1111/j.1365-2265.2012.04500.x
61
Sara De Nucci, Caterina Bonfiglio, Rosanna Donvito, Martina Di Chito, Nicole Cerabino, Roberta Rinaldi, Annamaria Sila, Endrit Shahini, Vito Giannuzzi, Pasqua Letizia Pesole, Sergio Coletta, Elsa Lanzilotta, Giuseppina Piazzolla, Raffaele Cozzolongo, Gianluigi Giannelli, Giovanni De Pergola. Effects of an Eight Week Very Low-Calorie Ketogenic Diet (VLCKD) on White Blood Cell and Platelet Counts in Relation to Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Subjects with Overweight and Obesity. Nutrients 2023; 15(20) doi: 10.3390/nu15204468
62
Taesic Lee, Tae-Ha Chung. Comparative analysis of the relationship between four hepatic steatosis indices and muscle mass. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-28751-5
63
Amany Abdin, Naglaa Sarhan. Resveratrol protects against experimental induced Reye’s syndrome by prohibition of oxidative stress and restoration of complex I activity. Canadian Journal of Physiology and Pharmacology 2014; 92(9) doi: 10.1139/cjpp-2014-0251
64
Misaq Heydari, María Eugenia Cornide-Petronio, Mónica B. Jiménez-Castro, Carmen Peralta. Data on Adiponectin from 2010 to 2020: Therapeutic Target and Prognostic Factor for Liver Diseases?. International Journal of Molecular Sciences 2020; 21(15) doi: 10.3390/ijms21155242
65
Alice Chaplin, Ramon Maria Rodriguez, Juan José Segura-Sampedro, Aina Ochogavía-Seguí, Dora Romaguera, Gwendolyn Barceló-Coblijn. Insights behind the Relationship between Colorectal Cancer and Obesity: Is Visceral Adipose Tissue the Missing Link?. International Journal of Molecular Sciences 2022; 23(21) doi: 10.3390/ijms232113128
66
Yik Lung Chan, Sonia Saad, David Simar, Brian Oliver, Kristine McGrath, David van Reyk, Paul P Bertrand, Cathy Gorrie, Carol Pollock, Hui Chen. Short term exendin‐4 treatment reduces markers of metabolic disorders in female offspring of obese rat dams. International Journal of Developmental Neuroscience 2015; 46(1) doi: 10.1016/j.ijdevneu.2015.05.009
67
Aneeqa Imtiaz, Muhammad Talha Bin Tahir, Minmeng Zhao, Daoqing Gong, Jing Ge, Tuoyu Geng. Non-Alcoholic Fatty Liver Disease in Poultry: Risk Factors, Mechanism of Development, and Emerging Strategies. International Journal of Molecular Sciences 2025; 26(17) doi: 10.3390/ijms26178460
68
Anna Bertolini, Frank A. J. A. Bodewes, Mordechai Slae, Michael Wilschanski. Cystic Fibrosis. Respiratory Medicine 2020;  doi: 10.1007/978-3-030-42382-7_14
69
. 2018;  doi: 10.70675/8206031dz8e5dz47a9z965az67fe5f7e19b6
70
Sechang Oh, Kiyoji Tanaka, Eiji Warabi, Junichi Shoda. Exercise Reduces Inflammation and Oxidative Stress in Obesity-Related Liver Diseases. Medicine & Science in Sports & Exercise 2013; 45(12) doi: 10.1249/MSS.0b013e31829afc33
71
Michael Doulberis, Stergios A. Polyzos, Apostolis Papaefthymiou, Panagiotis Katsinelos, Christos Kiosses, Jannis Kountouras. Treatment of nonalcoholic fatty liver disease: from adult trials to perspectives in the management of children and adolescents. Expert Opinion on Pharmacotherapy 2020; 21(3) doi: 10.1080/14656566.2019.1702967
72
Constantine E. Kosmas, Hassan Alkhawam, Mohammed El-Hunjul, Gabriel Wagman, Timothy J. Vittorio, Mark R. Kahn, Kathleen M. Grady. Statin-Mediated Low-Density Lipoprotein Lowering in Chronic Congestive Heart Failure. The American Journal of the Medical Sciences 2014; 347(1) doi: 10.1097/MAJ.0b013e318273514c
73
Min-Ji Kim, Min-Su Kim, Han-Byul Lee, Jae-Hyung Roh, Jae-Han Jeon. Relationship between the High Fatty Liver Index and Risk of Fracture. Gut and Liver 2023; 17(1) doi: 10.5009/gnl210571
74
Dagmara Kociszewska, Srdjan Vlajkovic. Age-Related Hearing Loss: The Link between Inflammaging, Immunosenescence, and Gut Dysbiosis. International Journal of Molecular Sciences 2022; 23(13) doi: 10.3390/ijms23137348
75
Ansoumane Kourouma, Hady Keita, Peng Duan, Chao Quan, Koikoi Kebe Bilivogui, Suqin Qi, Ndjiembi Adjonga Christiane, Aidogie Osamuyimen, Kedi Yang. Effects of 4-nonylphenol on oxidant/antioxidant balance system inducing hepatic steatosis in male rat. Toxicology Reports 2015; 2 doi: 10.1016/j.toxrep.2015.10.006
76
Rosa Reddavide, Anna Maria Cisternino, Rosa Inguaggiato, Ornella Rotolo, Iris Zinzi, Nicola Veronese, Vito Guerra, Fabio Fucilli, Giuseppe Di Giovanni, Gioacchino Leandro, Sara Giannico, Maria Gabriella Caruso. Non-Alcoholic Fatty Liver Disease Is Associated with Higher Metabolic Expenditure in Overweight and Obese Subjects: A Case-Control Study. Nutrients 2019; 11(8) doi: 10.3390/nu11081830
77
Chencheng Hu, Qian Yang, Runzhi Yu, Shuwei Hu, Bing Meng, Yanyong Xu. Hepatic activating transcription factor 3 protects against systemic inflammation by attenuating lipotoxicity. Metabolism Open 2025; 28 doi: 10.1016/j.metop.2025.100417
78
Hyeon-Jeong Kim, Sanghwa Kim, Ah Young Lee, Yoonjeong Jang, Orkhonselenge Davaadamdin, Seong-Ho Hong, Jun Sung Kim, Myung-Haing Cho. The Effects of Gymnema sylvestre in High-Fat Diet-Induced Metabolic Disorders. The American Journal of Chinese Medicine 2017; 45(04) doi: 10.1142/S0192415X17500434
79
Francesco Balestra, Maria De Luca, Giorgia Panzetta, Nicoletta Depalo, Federica Rizzi, Rita Mastrogiacomo, Sergio Coletta, Grazia Serino, Emanuele Piccinno, Dolores Stabile, Pasqua Letizia Pesole, Valentina De Nunzio, Giuliano Pinto, Nicole Cerabino, Martina Di Chito, Maria Notarnicola, Endrit Shahini, Giovanni De Pergola, Maria Principia Scavo. An 8-Week Very Low-Calorie Ketogenic Diet (VLCKD) Alters the Landscape of Obese-Derived Small Extracellular Vesicles (sEVs), Redefining Hepatic Cell Phenotypes. Nutrients 2024; 16(23) doi: 10.3390/nu16234189
80
Nicola Balato, Maddalena Napolitano, Fabio Ayala, Cataldo Patruno, Matteo Megna, Giovanni Tarantino. Nonalcoholic fatty liver disease, spleen and psoriasis: New aspects of low-grade chronic inflammation. World Journal of Gastroenterology 2015; 21(22): 6892-6897 doi: 10.3748/wjg.v21.i22.6892
81
Xiaobing Zhang, Yunfei Song, Yipei Ding, Wei Wang, Ling Liao, Jin Zhong, Pengbo Sun, Fan Lei, Yaou Zhang, Weidong Xie. Effects of Mogrosides on High-Fat-Diet-Induced Obesity and Nonalcoholic Fatty Liver Disease in Mice. Molecules 2018; 23(8) doi: 10.3390/molecules23081894
82
Xi Li, Yangjun Yang, Yi Sun, Shuzhe Ding. Research Progress on Lipophagy-Mediated Exercise Intervention in Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2024; 25(6) doi: 10.3390/ijms25063153
83
Hongzhi Chen, Juli Bai, Feng Dong, Hezhi Fang, Yun Zhang, Wen Meng, Bilian Liu, Yan Luo, Meilian Liu, Yidong Bai, Muhammad A. Abdul‐Ghani, Rongxia Li, Jiarui Wu, Rong Zeng, Zhiguang Zhou, Lily Q. Dong, Feng Liu. Hepatic DsbA‐L protects mice from diet‐induced hepatosteatosis and insulin resistance. The FASEB Journal 2017; 31(6) doi: 10.1096/fj.201600985R
84
Annamaria Sila, Sara De Nucci, Caterina Bonfiglio, Vincenza Di Stasi, Nicole Cerabino, Martina Di Chito, Roberta Rinaldi, Paola Cantalice, Endrit Shahini, Vito Giannuzzi, Pasqua Letizia Pesole, Sergio Coletta, Nicoletta Maria Tutino, Giuseppina Piazzolla, Raffaele Cozzolongo, Gianluigi Giannelli, Giovanni De Pergola. Higher-Level Steatosis Is Associated with a Greater Decrease in Metabolic Dysfunction-Associated Steatoic Liver Disease after Eight Weeks of a Very Low-Calorie Ketogenic Diet (VLCKD) in Subjects Affected by Overweight and Obesity. Nutrients 2024; 16(6) doi: 10.3390/nu16060874
85
Walaa Abdulhussein Al-Azzawi, Hamid Yaghooti, Hussein Al-Hakeim, Michael Maes. Neuro-immune and metabolic disorders in association with depression, anxiety, and chronic fatigue-fibromyalgia symptoms due to nonalcoholic fatty liver disease. CNS Spectrums 2026; 31(1) doi: 10.1017/S1092852926100960
86
Xue Cheng, Dongxiao Gao, Bin Chen, Xueying Mao. Endotoxin-Binding Peptides Derived from Casein Glycomacropeptide Inhibit Lipopolysaccharide-Stimulated Inflammatory Responses via Blockade of NF-κB activation in macrophages. Nutrients 2015; 7(5) doi: 10.3390/nu7053119
87
Sang R. Lee, Sun Woo Kwon, Pelin Kaya, Young Ho Lee, Jong Geol Lee, Globinna Kim, Geun-Shik Lee, In-Jeoung Baek, Eui-Ju Hong. Loss of progesterone receptor membrane component 1 promotes hepatic steatosis via the induced de novo lipogenesis. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-34148-6
88
Lei Liu, Changfa Wang, Zhongyang Hu, Shuwen Deng, Saiqi Yang, Xiaoling Zhu, Yuling Deng, Yaqin Wang. Not only baseline but cumulative exposure of remnant cholesterol predicts the development of nonalcoholic fatty liver disease: a cohort study. Environmental Health and Preventive Medicine 2024; 29(0) doi: 10.1265/ehpm.23-00289
89
Milena N. Stanković, Dušan R. Mladenović, Ivana Đuričić, Slađana S. Šobajić, Jasmina Timić, Bojan Jorgačević, Vuk Aleksić, Danijela B. Vučević, Rada Ješić-Vukićević, Tatjana S. Radosavljević. Time-dependent Changes and Association Between Liver Free Fatty Acids, Serum Lipid Profile and Histological Features in Mice Model of Nonalcoholic Fatty Liver Disease. Archives of Medical Research 2014; 45(2) doi: 10.1016/j.arcmed.2013.12.010
90
Maria-Angeles Aller, Natalia Arias, Isabel Prieto, Luis Santamaria, Maria-Paz de Miguel, Jorge-Luis Arias, Jaime Arias. Portal hypertension-related inflammatory phenotypes: From a vitelline and amniotic point of view. Advances in Bioscience and Biotechnology 2012; 3(07) doi: 10.4236/abb.2012.37110
91
Guiyuan Ji, Yuqi Wang, Yingxun Deng, Xin Li, Zhuoqin Jiang. Resveratrol ameliorates hepatic steatosis and inflammation in methionine/choline-deficient diet-induced steatohepatitis through regulating autophagy. Lipids in Health and Disease 2015; 14(1) doi: 10.1186/s12944-015-0139-6
92
Dong Hun Lee, Il Ho Lee, Jin Tae Hong. Fermented field water-dropwort (Oenanthe javanica) alleviates diet-induced non-alcoholic steatohepatitis. Food and Agricultural Immunology 2022; 33(1) doi: 10.1080/09540105.2021.2022603
93
Yanqi Lan, Zhinan Guo, Junsheng Dai, Kailin Chen, Youlan Chen. Association between remnant cholesterol and metabolic dysfunction-associated steatotic liver disease in the elderly. Digestive and Liver Disease 2024; 56(9) doi: 10.1016/j.dld.2024.03.013
94
. 2019;  doi: 10.70675/ff26d7c8z4c5fz4c86z9e6ezd8d843268447
95
Xuan Ma, Qingyi Zhou, Chen Ma, Jie Sheng, Xinghe Jiang, Guanqi Gao, Baolan Ji. Hepatic steatosis index as an independent predictor of hypertension in patients with type 2 diabetes: a cross-sectional study. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1697412
96
Wen-Bo Wang, Fei She, Li-Fang Xie, Wen-Hua Yan, Jin-Zhi Ouyang, Bao-An Wang, Hang-Yun Ma, Li Zang, Yi-Ming Mu. Evaluation of Basal Serum Adrenocorticotropic Hormone and Cortisol Levels and Their Relationship with Nonalcoholic Fatty Liver Disease in Male Patients with Idiopathic Hypogonadotropic Hypogonadism. Chinese Medical Journal 2016; 129(10) doi: 10.4103/0366-6999.181967
97
Arnab Banerjee, Debasmita Das, Sandip Mukherjee, Bithin Kumar Maji. Comprehensive study of the interplay between immunological and metabolic factors in hepatic steatosis. International Immunopharmacology 2024; 133 doi: 10.1016/j.intimp.2024.112091
98
Shaoguang Chen, Lixiao Zhu, Yulou Jiang. Inflammation burden index as a complementary marker for the assessment of hepatic steatosis and fibrosis: evidence from NHANES 2017–2018. Abdominal Radiology 2026; 51(9) doi: 10.1007/s00261-026-05414-3
99
Pamela Maffioli, Giuseppe Derosa. Biomarkers in Bone Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2017;  doi: 10.1007/978-94-007-7693-7_24
100
Teresa Auguet, Laia Bertran, Jessica Binetti, Carmen Aguilar, Salomé Martínez, Fàtima Sabench, Jesús Miguel Lopez-Dupla, José Antonio Porras, David Riesco, Daniel Del Castillo, Cristóbal Richart. Relationship between IL-8 Circulating Levels and TLR2 Hepatic Expression in Women with Morbid Obesity and Nonalcoholic Steatohepatitis. International Journal of Molecular Sciences 2020; 21(11) doi: 10.3390/ijms21114189
101
. 2019;  doi: 10.70675/01997f55za990z41e6z96baz8221de2a6281
102
Sunmi Kim, Hyuktae Kwon, Jin-Ho Park, Belong Cho, Donghee Kim, Seung-Won Oh, Cheol Min Lee, Ho-Chun Choi. A low level of serum total testosterone is independently associated with nonalcoholic fatty liver disease. BMC Gastroenterology 2012; 12(1) doi: 10.1186/1471-230X-12-69
103
Hessah Al‑Muzafar, Kamal Amin. Thiazolidinedione induces a therapeutic effect on hepatosteatosis by regulating stearoyl‑CoA desaturase‑1, lipase activity, leptin and resistin. Experimental and Therapeutic Medicine 2018;  doi: 10.3892/etm.2018.6563
104
Adeeb Shehzad, Taewook Ha, Fazli Subhan, Young Sup Lee. New mechanisms and the anti-inflammatory role of curcumin in obesity and obesity-related metabolic diseases. European Journal of Nutrition 2011; 50(3) doi: 10.1007/s00394-011-0188-1
105
Giovanni Tarantino, Vincenzo Citro, Clara Balsano. Liver-spleen axis in nonalcoholic fatty liver disease. Expert Review of Gastroenterology & Hepatology 2021; 15(7) doi: 10.1080/17474124.2021.1914587
106
Yajing Cheng, Wenjin Chen, Jia Xu, Hang Liu, Ting Chen, Jun Hu. Genetic analysis of potential biomarkers and therapeutic targets in age-related hearing loss. Hearing Research 2023; 439 doi: 10.1016/j.heares.2023.108894
107
Giovanni Tarantino, Vincenzo Citro. Could Adverse Effects of Antibiotics Due to Their Use/Misuse Be Linked to Some Mechanisms Related to Nonalcoholic Fatty Liver Disease?. International Journal of Molecular Sciences 2024; 25(4) doi: 10.3390/ijms25041993
108
Sherif A. Kamar, Yosra M. Magdy, Tamer M. M. Abuamara, Amina A. Sedky, Tahani Mohamed Ibrahim Al-Hazani, Maha Alhelf, Eman Serry Zayed, Tarek A. A. Yousef, Abdullah Al-Dakhil, Mortaga M. Abou-Krisha, Samah J. Almehmadi, Sara Khedr. The Effect of Liraglutide on the Hypolipidemic, Anti-Inflammatory, and Antioxidant Properties of Atorvastatin Mediated via the Nrf2/HO-1 Signaling Pathway: In Vivo and In Silico Validation. Pharmaceutics 2026; 18(4) doi: 10.3390/pharmaceutics18040490
109
. Advances in Clinical Chemistry 2014; 63 doi: 10.1016/B978-0-12-800094-6.00007-8
110
Giovanni Tarantino, Carmine Finelli. Handbook of Lipids in Human Function. 2016;  doi: 10.1016/B978-1-63067-036-8.00028-7
111
Akinobu Nakamura, Yasuo Terauchi. Lessons from Mouse Models of High-Fat Diet-Induced NAFLD. International Journal of Molecular Sciences 2013; 14(11) doi: 10.3390/ijms141121240
112
Walaa Hegazy, Adel Abdel-Moneim, Eman S. Abdel-Rehiem, Marwa Salah, Manal Abdul-Hamid. The protective effect of hesperidin on the liver of hypothyroid rats mediated by nuclear factor erythroid 2-related factor 2-dependent activation of heme oxygenase 1. Journal of Molecular Histology 2022; 53(3) doi: 10.1007/s10735-022-10066-w
113
Suelem Izumi, Fernando F. Ribeiro-Filho, Gláucia Carneiro, Sônia M. Togeiro, Sérgio Tufik, Maria T. Zanella. IGF-1 Levels are Inversely Associated With Metabolic Syndrome in Obstructive Sleep Apnea. Journal of Clinical Sleep Medicine 2016; 12(4) doi: 10.5664/jcsm.5672
114
Wenxuan Zhang, Bing Gao, Yaping Wang, Yuxiang Cao, Jing Wang. The relationship between hepatic steatosis index and hypertension: NHANES 2011–2018. BMC Cardiovascular Disorders 2025; 25(1) doi: 10.1186/s12872-025-04744-2
115
Avni Mody, Donna White, Fasiha Kanwal, Jose M. Garcia. Relevance of low testosterone to nonalcoholic fatty liver disease. Cardiovascular Endocrinology 2015; 4(3) doi: 10.1097/XCE.0000000000000057
116
Emina Čolak, Dragana Pap. The role of oxidative stress in the development of obesity and obesity-related metabolic disorders. Journal of Medical Biochemistry 2021; 40(1) doi: 10.5937/jomb0-24652
117
Anna Hadjihambi. Cerebrovascular alterations in NAFLD: Is it increasing our risk of Alzheimer's disease?. Analytical Biochemistry 2022; 636 doi: 10.1016/j.ab.2021.114387
118
Guanghua Xiong, Yunyun Deng, Xinjun Liao, Jun’e Zhang, Bo Cheng, Zigang Cao, Huiqiang Lu. Graphene oxide nanoparticles induce hepatic dysfunction through the regulation of innate immune signaling in zebrafish (Danio rerio). Nanotoxicology 2020; 14(5) doi: 10.1080/17435390.2020.1735552
119
Kazuyoshi Shigehara, Yuki Kato, Rei Shinzawa, Hiroyuki Konaka, Shohei Kawaguchi, Takahiro Nohara, Kouji Izumi, Mikio Namiki, Atsushi Mizokami. Testosterone Replacement Therapy Can Improve a Biomarker of Liver Fibrosis in Hypogonadal Men: A Subanalysis of a Prospective Randomized Controlled Study in Japan (EARTH Study). The World Journal of Men's Health 2025; 43(3) doi: 10.5534/wjmh.240066
120
Mengsong Liu, Jia Jiang, Zexin Wang, Xiao Ma, Jinhao Zeng, Jianyuan Tang. Preclinical evidence and multi-omics insights into the protective effects of epigallocatechin-3-gallate against high-fat diet-induced adverse health outcomes. Phytomedicine 2026; 161 doi: 10.1016/j.phymed.2026.158750
121
Silvia Savastano, Carolina Di Somma, Luigi Barrea, Annamaria Colao. The complex relationship between obesity and the somatropic axis: The long and winding road. Growth Hormone & IGF Research 2014; 24(6) doi: 10.1016/j.ghir.2014.09.002
122
I-Pin Chou, Yao-Pang Chiu, Shih-Torng Ding, Bing-Hsien Liu, Yuan Yu Lin, Ching-Yi Chen. Adiponectin receptor 1 overexpression reduces lipid accumulation and hypertrophy in the heart of diet-induced obese mice – possible involvement of oxidative stress and autophagy. Endocrine Research 2014; 39(4) doi: 10.3109/07435800.2013.879165
123
Soumojit Pal, Poulomi Nath, Debabrata Das, Sudip Hajra, Sudipta Maitra. Cross-talk between insulin signalling and LPS responses in mouse macrophages. Molecular and Cellular Endocrinology 2018; 476 doi: 10.1016/j.mce.2018.04.009
124
Pamela Maffioli, Giuseppe Derosa. Biomarkers in Bone Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2015;  doi: 10.1007/978-94-007-7745-3_24-1
125
Qiuyang Chen, Taisiia Shevchenko, Dewen Zhan, Ningning Ma, Sander Lefere, Joost Boeckmans, Joery De Kock, Freddy Van Goethem, Yong He, Tamara Vanhaecke, Robim M. Rodrigues. Molecular smugglers in obesity-driven MASLD: snitching on adipose-derived extracellular vesicles. Acta Pharmaceutica Sinica B 2026;  doi: 10.1016/j.apsb.2026.08.025
126
Mary Sugden, Mark Holness. Recent advances in biomarkers for noninvasive diagnosis of nonalcoholic steatohepatitis: the role of lipid analysis/ profiling. Clinical Lipidology 2011; 6(4) doi: 10.2217/clp.11.30
127
Stefanos Tyrovolas, Demosthenes B. Panagiotakos, Ekavi N. Georgousopoulou, Christina Chrysohoou, John Skoumas, William Pan, Dimitrios Tousoulis, Christos Pitsavos. The anti-inflammatory potential of diet and nonalcoholic fatty liver disease: the ATTICA study. Therapeutic Advances in Gastroenterology 2019; 12 doi: 10.1177/1756284819858039
128
Giovanni Tarantino, Carmine Finelli, Franco Scopacasa, Fabrizio Pasanisi, Franco Contaldo, Domenico Capone, Silvia Savastano. Circulating Levels of Sirtuin 4, a Potential Marker of Oxidative Metabolism, Related to Coronary Artery Disease in Obese Patients Suffering from NAFLD, with Normal or Slightly Increased Liver Enzymes. Oxidative Medicine and Cellular Longevity 2014; 2014 doi: 10.1155/2014/920676
129
Sung Woo Choi, Heeseung Oh, Seung Yeon Park, Wonjun Cho, A.M. Abd El-Aty, Nurcan Kilic Baygutalp, Ji Hoon Jeong, Tae Woo Jung. Netrin-1 attenuates hepatic steatosis via UNC5b/PPARγ-mediated suppression of inflammation and ER stress. Life Sciences 2022; 311 doi: 10.1016/j.lfs.2022.121149
130
Danial Fotros, Ali Jafari, Azita Hekmatdoost, Marieh Salavatizadeh, Hossein Poustchi, Mohammad Ebrahim Khamseh, Zahra Yari. Associations of the insulinemic potential of diet and lifestyle with metabolic dysfunction-associated steatotic liver disease (MASLD) risk in adults with type 2 diabetes. Scientific Reports 2026; 16(1) doi: 10.1038/s41598-026-58610-y
131
Anna Hernández-Aguilera, Anna Rull, Esther Rodríguez-Gallego, Marta Riera-Borrull, Fedra Luciano-Mateo, Jordi Camps, Javier A. Menéndez, Jorge Joven. Mitochondrial Dysfunction: A Basic Mechanism in Inflammation-Related Non-Communicable Diseases and Therapeutic Opportunities. Mediators of Inflammation 2013; 2013 doi: 10.1155/2013/135698
132
Lynn H. Gerber, Ali Weinstein, Lisa Pawloski. Role of Exercise in Optimizing the Functional Status of Patients with Nonalcoholic Fatty Liver Disease. Clinics in Liver Disease 2014; 18(1) doi: 10.1016/j.cld.2013.09.016
133
Marta Melis, Xiao-Han Tang, Steven E. Trasino, Viral M. Patel, Daniel J. Stummer, Jose Jessurun, Lorraine J. Gudas, Michael Schubert. Effects of AM80 compared to AC261066 in a high fat diet mouse model of liver disease. PLOS ONE 2019; 14(1) doi: 10.1371/journal.pone.0211071
134
Jordi Camps, Anabel García-Heredia. Oxidative Stress and Inflammation in Non-communicable Diseases - Molecular Mechanisms and Perspectives in Therapeutics. Advances in Experimental Medicine and Biology 2014; 824 doi: 10.1007/978-3-319-07320-0_1
135
Federico Greco, Claudia Lucia Piccolo, Valerio D’Andrea, Arnaldo Scardapane, Bruno Beomonte Zobel, Carlo Augusto Mallio. Fat Matters: Exploring Cancer Risk through the Lens of Computed Tomography and Visceral Adiposity. Journal of Clinical Medicine 2024; 13(2) doi: 10.3390/jcm13020453
136
Hae Jin Yang, Sang Goon Shim, Bong Oh Ma, Ji Yeong Kwak. Association of nonalcoholic fatty liver disease with bone mineral density and serum osteocalcin levels in Korean men. European Journal of Gastroenterology & Hepatology 2016; 28(3) doi: 10.1097/MEG.0000000000000535
137
Liqing Jiang, Qian Wang, Yingsong Jiang, Dadi Peng, Kezhen Zong, Shan Li, Wenyuan Xie, Cheng Zhang, Kaili Li, Zhongjun Wu, Zuotian Huang. Identification of diagnostic gene signatures and molecular mechanisms for non-alcoholic fatty liver disease and Alzheimer’s disease through machine learning algorithms. Clinica Chimica Acta 2024; 557 doi: 10.1016/j.cca.2024.117892
138
Debrup Chakraborty, Jing Wang. Nonalcoholic fatty liver disease and colorectal cancer: Correlation and missing links. Life Sciences 2020; 262 doi: 10.1016/j.lfs.2020.118507
139
Hong-Ai Zhang, Xiao-Yan Yang, Yan-Feng Xiao. AMPKα1 overexpression alleviates the hepatocyte model of nonalcoholic fatty liver disease via inactivating p38MAPK pathway. Biochemical and Biophysical Research Communications 2016; 474(2) doi: 10.1016/j.bbrc.2016.04.111
140
Sara Shojaei‐Zarghani, Ali Reza Safarpour, Mohammad Reza Fattahi, Abbasali Keshtkar. Sodium in relation with nonalcoholic fatty liver disease: A systematic review and meta‐analysis of observational studies. Food Science & Nutrition 2022; 10(5) doi: 10.1002/fsn3.2781
141
So Hee Lee, Min Ho An, Min-Gyu Kim, Hanki Kim, Soon Sang Park. Statin use and survival outcomes in colorectal cancer patients with hepatic steatosis evaluated by fatty liver index: a nationwide cohort study. Precision and Future Medicine 2026; 10(2) doi: 10.23838/pfm.2026.00065
142
Marco Bertolotti, Amedeo Lonardo, Chiara Mussi, Enrica Baldelli, Elisa Pellegrini, Stefano Ballestri, Dante Romagnoli, Paola Loria. Nonalcoholic fatty liver disease and aging: Epidemiology to management. World Journal of Gastroenterology 2014; 20(39): 14185-14204 doi: 10.3748/wjg.v20.i39.14185
143
Yong Jian Zhou, Zong Sheng Zhang, Yu Qiang Nie, Jie Cao, Chuang Yu Cao, Yu Yuan Li. Retracted: Association of adiponectin gene variation with progression of nonalcoholic fatty liver disease: A 4‐year follow‐up survey. Journal of Digestive Diseases 2015; 16(10) doi: 10.1111/1751-2980.12288
144
Sherif M. Shoieb, Mahmoud A. El-Ghiaty, Mohammed A. Alqahtani, Ayman O.S. El-Kadi. Cytochrome P450-derived eicosanoids and inflammation in liver diseases. Prostaglandins & Other Lipid Mediators 2020; 147 doi: 10.1016/j.prostaglandins.2019.106400
145
Nila Ganamurali, Sarvesh Sabarathinam. Digoxin-induced gut dysbiosis: Mechanistic links to prostaglandin dysregulation and lipid metabolic imbalance. Prostaglandins & Other Lipid Mediators 2026; 182 doi: 10.1016/j.prostaglandins.2025.107055
146
Xiaxian Tan, Xiaomin Hou, Yuan Wen, Yuhua Huang, Shenghua Qin. Association between body composition and metabolic dysfunction-associated steatotic liver disease in Chinese general population: a cross-sectional study stratified by sex and obesity status. Frontiers in Public Health 2026; 14 doi: 10.3389/fpubh.2026.1921631
147
Iben M. Miller, Astrid Vindsand Naver, Ulla B. Mogensen, Kian Zarchi, Hans C. Ring, Christina Ellervik, Gregor B.E. Jemec. Gallstones are associated with hidradenitis suppurativa. European Journal of Gastroenterology & Hepatology 2015; 27(12) doi: 10.1097/MEG.0000000000000469
148
Raghdaa Al Zarzour, Mohammed Alshawsh, Muhammad Asif, Majed Al-Mansoub, Zahurin Mohamed, Mariam Ahmad, Amin Abdul Majid, Mohd. Asmawi, Gurjeet Kaur, Dhamraa Al-dualimi, Mun Yam. Adipocytokine Regulation and Antiangiogenic Activity Underlie the Molecular Mechanisms of Therapeutic Effects of Phyllanthus niruri against Non-Alcoholic Fatty Liver Disease. Nutrients 2018; 10(8) doi: 10.3390/nu10081057
149
Jaw Long Sun, Jinwoo Park, Taeseung Lee, Ji Hoon Jeong, Tae Woo Jung. DEL-1 ameliorates high-fat diet-induced insulin resistance in mouse skeletal muscle through SIRT1/SERCA2-mediated ER stress suppression. Biochemical Pharmacology 2020; 171 doi: 10.1016/j.bcp.2019.113730
150
Mohamed Asrih, François R Jornayvaz. Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance. Journal of Endocrinology 2013; 218(3) doi: 10.1530/JOE-13-0201
151
Soo Jin Yang, Yunsook Lim. Resveratrol ameliorates hepatic metaflammation and inhibits NLRP3 inflammasome activation. Metabolism 2014; 63(5) doi: 10.1016/j.metabol.2014.02.003
152
Asieh Mansour, Soudabe Motamed, Azita Hekmatdoost, Sara Karimi, Mohammad Reza Mohajeri-Tehrani, Mohammad Abdollahi, Reihane Jelodar, Sayed Mahmoud Sajjadi-Jazi. Factors related to hypermetabolism in individuals with type 2 diabetes mellitus and non-alcoholic fatty liver disease. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-30945-w
153
Anna Pastore, Anna Alisi, Gianna Di Giovamberardino, Annalisa Crudele, Sara Ceccarelli, Nadia Panera, Carlo Dionisi-Vici, Valerio Nobili. Plasma Levels of Homocysteine and Cysteine Increased in Pediatric NAFLD and Strongly Correlated with Severity of Liver Damage. International Journal of Molecular Sciences 2014; 15(11) doi: 10.3390/ijms151121202
154
Jayden Abdallah, Samantha Assaf, Arpita Das, Vasant Hirani. Effects of anti-inflammatory dietary patterns on non-alcoholic fatty liver disease: a systematic literature review. European Journal of Nutrition 2023; 62(4) doi: 10.1007/s00394-023-03085-0
155
Wei Wang, Caiyan Zhao, Junying Zhou, Zhen Zhen, Yadong Wang, Chuan Shen, Carlos M Rodriguez-Ortigosa. Simvastatin Ameliorates Liver Fibrosis via Mediating Nitric Oxide Synthase in Rats with Non-Alcoholic Steatohepatitis-Related Liver Fibrosis. PLoS ONE 2013; 8(10) doi: 10.1371/journal.pone.0076538
156
Okan Dikker, Hüseyin Dağ, Emine Türkkan, Nevin Çetin Dağ, Nafiye Emel Çakar. The relationship between zinc and hepatic steatosis. Journal of Surgery and Medicine 2019;  doi: 10.28982/josam.608618
157
Ying Zhao, Zhaoyue Li, Tian Yu, Yan Yang, Tingting Du. Discordant high remnant cholesterol with LDL-C increases the metabolic dysfunction-associated steatotic liver disease risk in patients with type 2 diabetes mellitus. BMJ Open Diabetes Research & Care 2026; 14(3) doi: 10.1136/bmjdrc-2025-005841
158
Carmine Finelli, Giovanni Tarantino. Should visceral fat, strictly linked to hepatic steatosis, be depleted to improve survival?. Hepatology International 2013; 7(2) doi: 10.1007/s12072-012-9406-z
159
Nupur Sharma, Sadam H. Bhat, Shweta Chaudhary, Babu Mathew, Sushmita Pandey, Sanju Yadav, Manisha Yadav, Vasundhra Bindal, Gaurav Tripathi, Neha Sharma, Vipul Sharma, Abhishak Gupta, Ranjan Nanda, Anupama Kumari, Shvetank Sharma, Jaswinder Singh Maras. In vivo protein half-life analysis identifies the SREBF1-SLC27a5 axis governs antioxidant response in preclinical alcoholic rat model. Redox Biology 2025; 85 doi: 10.1016/j.redox.2025.103674
160
Maria-Angeles Aller, Natalia Heras, Javier Blanco-Rivero, Jose-Ignacio Arias, Vicente Lahera, Gloria Balfagón, Jaime Arias. Portal hypertensive cardiovascular pathology: The rescue of ancestral survival mechanisms?. Clinics and Research in Hepatology and Gastroenterology 2012; 36(1) doi: 10.1016/j.clinre.2011.07.017
161
Yidian Fu, Chao Jiang, Zonglin Li, Xiangyun Shi, Peiyuan Lv, Jingbo Zhang. Association between the composite dietary antioxidant index and non-alcoholic fatty liver disease: evidence from National Health and Nutrition Examination Survey 2005–2016. Frontiers in Nutrition 2025; 12 doi: 10.3389/fnut.2025.1473487
162
Silvia Savastano, Carolina Di Somma, Annamaria Colao, Luigi Barrea, Francesco Orio, Carmine Finelli, Fabrizio Pasanisi, Franco Contaldo, Giovanni Tarantino. Preliminary data on the relationship between circulating levels of Sirtuin 4, anthropometric and metabolic parameters in obese subjects according to growth hormone/insulin-like growth factor-1 status. Growth Hormone & IGF Research 2015; 25(1) doi: 10.1016/j.ghir.2014.10.006
163
Kyung Eun Kim, Youngae Jung, Soonki Min, Miso Nam, Rok Won Heo, Byeong Tak Jeon, Dae Hyun Song, Chin-ok Yi, Eun Ae Jeong, Hwajin Kim, Jeonghyun Kim, Seon-Yong Jeong, Woori Kwak, Do Hyun Ryu, Tamas L. Horvath, Gu Seob Roh, Geum-Sook Hwang. Caloric restriction of db/db mice reverts hepatic steatosis and body weight with divergent hepatic metabolism. Scientific Reports 2016; 6(1) doi: 10.1038/srep30111
164
Hope Onohuean, Ngozi F. Nnolum-Orji, Sarad Pawar Naik Bukke, Kasim Sakran Abass, Abdullateef Isiaka Alagbonsi, Yahya E. Choonara. Non-alcoholic fatty pancreas disease (NAFPD) as a pre-neoplastic niche: Metabolic and inflammatory Gateways to pancreatic ductal adenocarcinoma. Journal of Clinical & Translational Endocrinology 2025; 42 doi: 10.1016/j.jcte.2025.100424
165
James W. Little, Donald A. Falace, Craig S. Miller, Nelson L. Rhodus. Little and Falace's Dental Management of the Medically Compromised Patient. 2013;  doi: 10.1016/B978-0-323-08028-6.00010-5
166
Un Jung, Myung-Sook Choi. Obesity and Its Metabolic Complications: The Role of Adipokines and the Relationship between Obesity, Inflammation, Insulin Resistance, Dyslipidemia and Nonalcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2014; 15(4) doi: 10.3390/ijms15046184
167
Matteo Nicola Dario Di Minno, Rosario Peluso, Salvatore Iervolino, Roberta Lupoli, Anna Russolillo, Giovanni Tarantino, Raffaele Scarpa. Hepatic steatosis, carotid plaques and achieving MDA in psoriatic arthritis patients starting TNF-α blockers treatment: a prospective study. Arthritis Research & Therapy 2012; 14(5) doi: 10.1186/ar4049
168
Mi Young Lee, Ran Choi, Hong Min Kim, Eun Ju Cho, Bo Hwan Kim, Yeon Sik Choi, Jarinyaporn Naowaboot, Eun Young Lee, Young Chul Yang, Jang Yel Shin, Young Goo Shin, Choon Hee Chung. Peroxisome proliferator-activated receptor δ agonist attenuates hepatic steatosis by anti-inflammatory mechanism. Experimental & Molecular Medicine 2012; 44(10) doi: 10.3858/emm.2012.44.10.066
169
Mathilde Foisy Sauvé, Schohraya Spahis, Edgard Delvin, Emile Levy. Glycomacropeptide: A Bioactive Milk Derivative to Alleviate Metabolic Syndrome Outcomes. Antioxidants & Redox Signaling 2021; 34(3) doi: 10.1089/ars.2019.7994
170
L. F. Torres, B. Cogliati, R. Otton. Green Tea Prevents NAFLD by Modulation of miR-34a and miR-194 Expression in a High-Fat Diet Mouse Model. Oxidative Medicine and Cellular Longevity 2019; 2019 doi: 10.1155/2019/4168380
171
Yanyan Xuan, Weike Hu, Yudan Wang, Jingwen Li, Lisha Yang, Songping Yu, Dongdong Zhou. Association between RC/HDL-C ratio and risk of non-alcoholic fatty liver disease in the United States. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1427138
172
Michal Ganz, Terence N Bukong, Timea Csak, Banishree Saha, Jin-Kyu Park, Aditya Ambade, Karen Kodys, Gyongyi Szabo. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat–cholesterol–sugar diet model in mice. Journal of Translational Medicine 2015; 13(1) doi: 10.1186/s12967-015-0552-7
173
Christopher Leung, Leni Rivera, John B. Furness, Peter W. Angus. The role of the gut microbiota in NAFLD. Nature Reviews Gastroenterology & Hepatology 2016; 13(7) doi: 10.1038/nrgastro.2016.85
174
Sara Arefhosseini, Neda Roshanravan, Helda Tutunchi, Somayyeh Rostami, Manuchehr Khoshbaten, Mehrangiz Ebrahimi-Mameghani. Myo-inositol supplementation improves cardiometabolic factors, anthropometric measures, and liver function in obese patients with non-alcoholic fatty liver disease. Frontiers in Nutrition 2023; 10 doi: 10.3389/fnut.2023.1092544
175
María-Angeles Aller, Natalia Arias, Sherezade Fuentes-Julian, Alejandro Blazquez-Martinez, Salvador Argudo, Maria-Paz de Miguel, Jorge-Luis Arias, Jaime Arias. Coupling inflammation with evo-devo. Medical Hypotheses 2012; 78(6) doi: 10.1016/j.mehy.2012.02.018
176
Jareth Jun Jie Ng, Wai Mun Loo, Kewin Tien Ho Siah. Associations between irritable bowel syndrome and non-alcoholic fatty liver disease: A systematic review. World Journal of Hepatology 2023; 15(7): 925-938 doi: 10.4254/wjh.v15.i7.925
177
Hye-Jin Kim, Hye-Jin Kang, Sangyi Lim, Ok Cheol Kim, Ki-Nam Yoon, Junhyeong Lee, Merc Emil Matienzo, Min-Jung Park, Bu-Soo Park, Jeong-Yong Cho, Seong-Jin Hong, Dong-il Kim, Young-Min Kim. Comparative study of rebaudioside A and rebaudioside Aα: physicochemical properties and in vivo metabolism. npj Science of Food 2025; 9(1) doi: 10.1038/s41538-025-00585-7
178
H. Nishizawa, G. Iguchi, A. Murawaki, H. Fukuoka, Y. Hayashi, H. Kaji, M. Yamamoto, K. Suda, M. Takahashi, Y. Seo, Y. Yano, R. Kitazawa, S. Kitazawa, M. Koga, Y. Okimura, K. Chihara, Y. Takahashi. Nonalcoholic fatty liver disease in adult hypopituitary patients with GH deficiency and the impact of GH replacement therapy. European Journal of Endocrinology 2012; 167(1) doi: 10.1530/EJE-12-0252
179
Jharna Puppala, Siva Prasad Siddapuram, Jyothy Akka, Anjana Munshi. Genetics of Nonalcoholic Fatty Liver Disease: An Overview. Journal of Genetics and Genomics 2013; 40(1) doi: 10.1016/j.jgg.2012.12.001
180
. 2018;  doi: 10.70675/881e84fazadd6z4a73zafdfzcf838fd002b4
181
. 2018;  doi: 10.70675/2fb92711z373cz4b27z8082z7aa3f8930e63
182
Hangkai Huang, Yanjun Guo, Zhening Liu, Yan Zeng, Yishu Chen, Chengfu Xu. Remnant Cholesterol Predicts Long-term Mortality of Patients With Metabolic Dysfunction–associated Fatty Liver Disease. The Journal of Clinical Endocrinology & Metabolism 2022; 107(8) doi: 10.1210/clinem/dgac283
183
Ying-Hsiang Wang, Chi-Hsiang Chung, Tien-Yu Huang, Chao-Feng Chang, Chi-Wei Yang, Wu-Chien Chien, Yi-Chiao Cheng. Association between nonalcoholic fatty liver disease and incidence of inflammatory bowel disease: a nationwide population‑based cohort study. Intestinal Research 2025; 23(1) doi: 10.5217/ir.2023.00078
184
Nadia Irfan, Yasir Nawaz, Muddasir Hassan Abbasi, Hafiza Fizzah Riaz, Javaria Zafar. RETRACTED: Exposure of Bisphenol S on Splenic Injury Causing Inflammation in Wistar Rat by Histological Analysis. Letters in Drug Design & Discovery 2025; 22(12) doi: 10.1016/j.lddd.2025.100202
185
Elena Daveri, Eleonora Cremonini, Angela Mastaloudis, Shelly N. Hester, Steven M. Wood, Andrew L. Waterhouse, Mauri Anderson, Cesar G. Fraga, Patricia I. Oteiza. Cyanidin and delphinidin modulate inflammation and altered redox signaling improving insulin resistance in high fat-fed mice. Redox Biology 2018; 18 doi: 10.1016/j.redox.2018.05.012
186
Ran Cui, Hui Sheng, Xue-Fei Rui, Xiao-Yun Cheng, Chun-Jun Sheng, Ji-Ying Wang, Shen Qu. Low Bone Mineral Density in Chinese Adults with Nonalcoholic Fatty Liver Disease. International Journal of Endocrinology 2013; 2013 doi: 10.1155/2013/396545
187
Sarahi Lopez‐Esparza, Laura C. Berumen, Karla Padilla, Ricardo Miledi, Guadalupe García‐Alcocer. Expression of hippocampal serotonin receptors 5‐HT2C and 5‐HT5A in a rat model of diet‐induced obesity supplemented with tryptophan. International Journal of Developmental Neuroscience 2015; 42(1) doi: 10.1016/j.ijdevneu.2015.02.010
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.